Order Article Reprints

Sitler CA, Tian C, Hamilton CA, Richardson MT, Chan JK, Kapp DS, Leath CA III, Casablanca Y, Washington C, Chappell NP, et al. Immuno-Molecular Targeted Therapy Use and Survival Benefit in Patients with Stage IVB Cervical Carcinoma in Commission on Cancer^®-Accredited Facilities in the United States. Cancers. 2024; 16(5):1071. https://doi.org/10.3390/cancers16051071

Sitler, Collin A., Chunqiao Tian, Chad A. Hamilton, Michael T. Richardson, John K. Chan, Daniel S. Kapp, Charles A. Leath, III, Yovanni Casablanca, Christina Washington, Nicole P. Chappell, and et al. 2024. "Immuno-Molecular Targeted Therapy Use and Survival Benefit in Patients with Stage IVB Cervical Carcinoma in Commission on Cancer^®-Accredited Facilities in the United States" Cancers 16, no. 5: 1071. https://doi.org/10.3390/cancers16051071

Sitler, C. A., Tian, C., Hamilton, C. A., Richardson, M. T., Chan, J. K., Kapp, D. S., Leath, C. A., III, Casablanca, Y., Washington, C., Chappell, N. P., Klopp, A. H., Shriver, C. D., Tarney, C. M., Bateman, N. W., Conrads, T. P., Maxwell, G. L., Phippen, N. T., & Darcy, K. M. (2024). Immuno-Molecular Targeted Therapy Use and Survival Benefit in Patients with Stage IVB Cervical Carcinoma in Commission on Cancer^®-Accredited Facilities in the United States. Cancers, 16(5), 1071. https://doi.org/10.3390/cancers16051071